|
PPP2R3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.074600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.280810E-01 |
| Normal-vs-Stage2 |
4.866200E-02 |
| Normal-vs-Stage3 |
8.366100E-02 |
| Normal-vs-Stage4 |
6.469600E-01 |
| Stage1-vs-Stage2 |
9.048300E-04 |
| Stage1-vs-Stage3 |
5.897400E-01 |
| Stage1-vs-Stage4 |
5.302200E-01 |
| Stage2-vs-Stage3 |
2.059300E-03 |
| Stage2-vs-Stage4 |
3.789900E-02 |
| Stage3-vs-Stage4 |
3.319600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.873500E-02 |
| Normal-vs-AfricanAmerican |
2.714400E-01 |
| Normal-vs-Asian |
6.594400E-01 |
| Caucasian-vs-AfricanAmerican |
7.175400E-01 |
| Caucasian-vs-Asian |
4.358800E-01 |
| AfricanAmerican-vs-Asian |
4.322800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.709630E-01 |
| Normal-vs-Female |
2.971400E-01 |
| Male-vs-Female |
5.135000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.223700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.645400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.470800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.397600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.072800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.259500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.452000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.069900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.717400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.846400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.342200E-01 |
| Classical-VS-Follicular |
2.55351295663786E-15 |
| Classical-VS-Other |
4.204000E-01 |
| Classical-VS-Normal |
4.138500E-03 |
| Tall-VS-Follicular |
9.4073004941464E-10 |
| Tall-VS-Other |
1.498970E-01 |
| Tall-VS-Normal |
1.784780E-03 |
| Follicular-VS-Other |
6.264400E-02 |
| Follicular-VS-Normal |
7.7021000000066E-05 |
| Other-VS-Normal |
9.140200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.852200E-01 |
| Normal-vs-N1 |
7.575800E-01 |
| N0-vs-N1 |
3.198800E-01 |
|
|
